Proteomic and Targeted Metabolomic Studies on a Silkworm Model of Parkinson's Disease.
暂无分享,去创建一个
Qi Tang | S. Huo | Xiaoyong Liu | F. Zhu | Shangshang Ma | Qian Yu | Jinying Han | Weiwei Zhou | Han Chen | Keping Chen | Keping Chen
[1] B. Melichar,et al. Determination of one year stability of lipid plasma profile and comparison of blood collection tubes using UHPSFC/MS and HILIC-UHPLC/MS. , 2020, Analytica chimica acta.
[2] K. Jóźwiak,et al. Recent developments of bioanalytical methods in determination of neurotransmitters in vivo. , 2019, Journal of pharmaceutical and biomedical analysis.
[3] Ashokkumar Balasubramaniem,et al. Oxidative stress response, epigenetic and behavioral alterations in Caenorhabditis elegans exposed to organophosphorus pesticide quinalphos , 2019, Biocatalysis and Agricultural Biotechnology.
[4] Y. Iwata,et al. Kynurenine pathway in depression: A systematic review and meta-analysis , 2018, Neuroscience & Biobehavioral Reviews.
[5] Ying Lin,et al. Wild Silkworm Cocoon Contains More Metabolites Than Domestic Silkworm Cocoon to Improve Its Protection , 2017, Journal of insect science.
[6] G. Akpinar,et al. Proteomic studies associated with Parkinson’s disease , 2017, Expert review of proteomics.
[7] G. Jékely,et al. Ancient coexistence of norepinephrine, tyramine, and octopamine signaling in bilaterians , 2016, BMC Biology.
[8] H. Bono,et al. Can the silkworm (Bombyx mori) be used as a human disease model? , 2016, Drug discoveries & therapeutics.
[9] H. Qing,et al. Differential expression of synaptic proteins in unilateral 6‐OHDA lesioned rat model—A comparative proteomics approach , 2014, Proteomics.
[10] H. Bono,et al. Identification of Key Uric Acid Synthesis Pathway in a Unique Mutant Silkworm Bombyx mori Model of Parkinson’s Disease , 2013, PloS one.
[11] P. Barone,et al. Neurotransmission in Parkinson’s disease: beyond dopamine , 2010, European journal of neurology.
[12] Ronald L. Davis,et al. Eight Different Types of Dopaminergic Neurons Innervate the Drosophila Mushroom Body Neuropil: Anatomical and Physiological Heterogeneity , 2009, Front. Neural Circuits.
[13] J. Klose,et al. Proteome analysis of ventral midbrain in MPTP‐treated normal and L1cam transgenic mice , 2008, Proteomics.
[14] Detlev Boison,et al. Adenosine as a neuromodulator in neurological diseases. , 2008, Current opinion in pharmacology.
[15] X. Pu,et al. Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson's disease , 2007, Proteomics. Clinical applications.
[16] H. Reichert,et al. Insights into the urbilaterian brain: conserved genetic patterning mechanisms in insect and vertebrate brain development , 2005, Heredity.
[17] Steven E. Hyman. Neurotransmitters , 2005, Current Biology.
[18] O. Hobert,et al. Functional mapping of neurons that control locomotory behavior in Caenorhabditis elegans. , 2003, Journal of neurobiology.
[19] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[20] U. Ungerstedt,et al. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.